参考文献/References:
[1]李晓盈,张鑫,张伟健,等.MLH1基因启动子甲基化在子宫内膜癌中的应用研究进展[J].陕西医学杂志,2025,54(5):711-715,720.
[2]ROLLET E,PUIGRENIER S,NAJEM A,et al.Successful immunotherapy rechallenge without recurrence of hemophagocytic lymphohistiocytosis in a patient with metastatic endometrial cancer previously treated with dostarlimab[J].World J Oncol,2025,16(6):661-663.
[3]MICHELS K A,JIN D,JESKE R,et al.Circulating biomarkers of infection and endometrial cancer risk[J].Cancer Causes Control,2025,36(12):2015-2022.
[4]周琴,黄丽琼,胡丽蓉,等.超声造影参数评估子宫内膜癌患者预后价值研究[J].陕西医学杂志,2024,53(8):1055-1059.
[5]王娟,霍艳花,李淑仙,等.子宫内膜癌组织中PLAGL2、SNX5表达情况与患者病理特征及预后的关系[J].转化医学杂志,2025,14(10):6-11.
[6]叶小琳,梁新丽,张超.子宫内膜癌组织KIF18B、ASF1B表达与患者临床病理特征和生存预后的关系[J].中国临床新医学,2025,18(9):1021-1026.
[7]于晓妮.乳酸脱氢酶（LDH）在子宫肌瘤及子宫肉瘤患者外周血及病理组织中的表达研究[D].青岛:青岛大学,2016.
[8]王季颖,苏斌,叶影,等.三基序蛋白29、三基序蛋白59对非小细胞肺癌细胞迁移能力的影响[J].中华实验外科杂志,2021,38(5):860-863.
[9]中国抗癌协会妇科肿瘤专业委员会.子宫内膜癌诊断与治疗指南（第四版）[J].中国实用妇科与产科杂志,2018,34(8):880-886．
[10]TALIENTO C,SCUTIERO G,CUCINELLA G,et al.Predictive factors for failed sentinel lymph node mapping in endometrial cancer:A retrospective multicenter study[J].J Surg Oncol,2025,132(8):1391-1398.
[11]FERGUSON D,SHIHAB S,BUTLER K,et al.Estrogen therapy use in early-stage endometrial cancer survivors[J].J Womens Health (Larchmt),2025,34(12):1569-1570.
[12]刘鉴瑶,李越,胡缓缓,等.基于炎症相关基因构建子宫内膜癌预后风险模型[J].遗传,2025,47(9):1007-1022.
[13]李红卫,游志辉.绝经后子宫内膜增厚发生子宫内膜癌的危险因素及其列线图预测模型构建[J].中南医学科学杂志,2025,53(5):929-932.
[14]何满珠,李境,潘如.子宫内膜癌ProMisE分子分型与淋巴结转移和临床特征的相关性[J].川北医学院学报,2025,40(9):1130-1133.
[15]李哲,李宁,吴令英.妇科恶性肿瘤精准诊疗进展[J].中华妇产科杂志,2025,60(9):748-752.
[16]李建,杨思慧,刘琦,等.雄激素受体与子宫内膜癌临床病理特征及预后关系研究[J].现代医学,2025,53(9):1511-1517.
[17]BATES-FRASER L C,MASTERS M,BODELON C,et al.Every move matters:Physical activity,walking,sedentary behavior,and endometrial cancer survival[J].Cancer Causes Control,2025,36(12):1743-1752.
[18]KPONEE-SHOVEIN K,PRABHU V S,SONG Y,et al.Clinical burden of recurrent disease in high-risk endometrial cancer[J].Oncol Ther,2025,13(4):1007-1021.
[19]宋克娟,于晓妮,吕腾,等.乳酸脱氢酶亚基在子宫肌瘤及子宫肉瘤中的表达及意义[J].现代妇产科进展,2017,26(7):509-512.
[20]申利,翁丹卉.茯苓酸抑制TRIM29表达通过Wnt信号通路调控宫颈癌细胞存活和凋亡[J].广州中医药大学学报,2020,37(1):140-146.
[21]马成蕾,张亚洁,仝建业,等.miR-146b-5p和TRIM29在子宫内膜癌中的表达[J].徐州医科大学学报,2023,43(1):59-64.
[22]范明喆,田永杰.三结构域家族蛋白在子宫内膜癌中的研究进展[J].山东第一医科大学学报,2022,43(6):471-476.
[23]刘峰,庄研,向江东,等.PTEN抑制子宫内膜癌细胞乳酸产生的研究[J].中国妇幼保健,2018,33(23):5331-5333.
[24]CAPACI V,ARRIGONI G,MONASTA L,et al.Phospho-DIGE identified phosphoproteins involved in pathways related to tumour growth in endometrial cancer[J].Int J Mol Sci,2023,24(15):11987.
[25]王进云,张深,任双双,等.子宫内膜癌同源重组修复缺陷相关基因表达及与临床病理特征、免疫浸润的关系[J].中国医师进修杂志,2024,47(7):617-623.
[26]SHEN L,WANG J,LI Y,et al.Transcription factor STAT3-activated LDHB promotes tumor properties of endometrial cancer cells by inducing MDH2 expression[J].Mol Biotechnol,2025,67(2):562-574.
[27]贾炎峰,吴珍珍.基于子宫内膜癌FIGO 2023分期下的淋巴结转移与分子分型相关性研究[J].现代妇产科进展,2025,34(8):571-576.
[28]宋艳,刘爱军.子宫内膜癌FIGO 2023分期的更新及其临床病理意义[J].中华妇产科杂志,2024,59(3):179-183.
[29]陈丹丹,楼云龙,宋丽,等.18F-FDG PET/CT代谢参数与子宫内膜癌相关临床病理特征的关系[J].中国临床医学影像杂志,2019,30(12):888-891.
[30]王陈,赵肖雅,刘岩,等.单纯性卵巢内膜样癌与子宫-卵巢同步性内膜样癌临床病理及分子特征比较分析[J].中华妇产科杂志,2026,61(1):50-59.
相似文献/References:
[1]冯苗苗,曹秋雨.miR335在子宫内膜癌患者血清中的表达及检测临床意义[J].陕西医学杂志,2019,(2):252.
FENG Miaomiao,CAO Qiuyu..The expression and significance of miR335 in serum of patients with endometrial carcinoma[J].,2019,(5):252.
[2]刘家利,谢小军.子宫内膜癌组织HIF-1α、血清CA125水平在患者病情与疾病预后评估中的价值[J].陕西医学杂志,2019,(6):800.
[3]张晓勇.宫腔镜辅助下分段诊刮术与单纯分段诊刮术诊断子宫内膜癌价值比较[J].陕西医学杂志,2019,(8):1045.
ZHANG Xiaoyong..Comparison of hysteroscopy assisted dilatation and curettage and traditional dilatation
and curettage in the diagnosis of endometrial carcinoma[J].,2019,(5):1045.
[4]徐 珊,程 珂,刘鹏宇.子宫内膜癌组织血管紧张素(1-7)、miR-106b表达与患者临床病理分期相关性研究[J].陕西医学杂志,2022,51(5):621.[doi:DOI:10.3969/j.issn.1000-7377.2022.05.025]
XU Shan,Cheng Ke,LIU Pengyu.Correlation between the expression of angiotensin(1-7),miR-106b in endometrial cancer tissue and clinicopathological stage of patients[J].,2022,51(5):621.[doi:DOI:10.3969/j.issn.1000-7377.2022.05.025]
[5]都 燕,代 佳.血清细胞角蛋白19片段、α-烯醇化酶检测在子宫内膜癌诊断及病情严重程度评估中的价值[J].陕西医学杂志,2023,52(2):212.[doi:DOI:10.3969/j.issn.1000-7377.2023.02.022]
DU Yan,DAI Jia.Value of serum cytokeratin 19 fragment and α-enolase detection in diagnosis and severity assessment of endometrial carcinoma[J].,2023,52(5):212.[doi:DOI:10.3969/j.issn.1000-7377.2023.02.022]
[6]姚 田,马文娟.RP11-444D3.1与SOX5基因共表达激活cofilin/LIMK/Rac信号通路介导子宫内膜癌侵袭机制研究[J].陕西医学杂志,2023,52(4):390.[doi:DOI:10.3969/j.issn.1000-7377.2023.04.006]
YAO Tian,MA Wenjuan.Co-expression of RP11-444D3.1 and SOX5 enhances endometrial cancer invasion by activating cofilin/LIMK/Rac pathway[J].,2023,52(5):390.[doi:DOI:10.3969/j.issn.1000-7377.2023.04.006]
[7]查善辉,刘 杰,任 洁,等.腹腔镜手术治疗老年子宫内膜癌疗效及对患者应激、疼痛和术后恢复的影响[J].陕西医学杂志,2023,52(5):536.[doi:DOI:10.3969/j.issn.1000-7377.2023.05.009]
ZHA Shanhui,LIU Jie,REN Jie,et al.Clinical effect of laparoscopic surgery in treatment of elderly endometrial cancer and its influence on patients' stress,pain and postoperative recovery[J].,2023,52(5):536.[doi:DOI:10.3969/j.issn.1000-7377.2023.05.009]
[8]冯一平,袁浩鑫,曾尚云,等.肿瘤坏死因子受体相关因子6高表达对子宫内膜癌细胞侵袭、迁移及上皮间质转化的影响[J].陕西医学杂志,2023,52(11):1598.[doi:DOI:10.3969/j.issn.1000-7377.2023.11.032]
FENG Yiping,YUAN Haoxin,ZENG Shangyun,et al.Effects of high expression of TRAF6 on invasion,migration and epithelial-mesenchymal transition of endometrial cancer cells[J].,2023,52(5):1598.[doi:DOI:10.3969/j.issn.1000-7377.2023.11.032]
[9]孔维娜,李 佳,赵淑华,等.代谢综合征在子宫内膜癌及其肿瘤微环境中的研究进展[J].陕西医学杂志,2023,52(11):1607.[doi:DOI:10.3969/j.issn.1000-7377.2023.11.034]
KONG Weina,LI Jia,ZHAO Shuhua,et al.Progress of metabolic syndrome in endometrial cancer and its tumor microenvironment[J].,2023,52(5):1607.[doi:DOI:10.3969/j.issn.1000-7377.2023.11.034]
[10]左学骞,赵海波,李 丹.三结构域蛋白8、Ras相关蛋白35、多聚ADP核糖聚合酶1在子宫内膜癌组织中的表达及检测临床意义[J].陕西医学杂志,2024,(2):266.[doi:DOI:10.3969/j.issn.1000-7377.2024.02.026]